AzTrials
AzTrials

PerformanceNCT01621074

Influence of Sodium Bicarbonate on Time-to-exhaustion at Critical Power in Endurance Athletes

A study testing Sodium bicarbonate in people with Performance, run by University of Zurich at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

During endurance exercise in the heavy and severe intensity domains, the rate at which metabolites that have been associated with the fatigue process (e.g. Pi, ADP, H, and extracellular K) accumulate increases. possibly leading to exercise cessation. Read more about this study

Who is it for?
Ages 18 to 45 years, men only
Conditions the study is for
Performance
What is being tested?
Sodium bicarbonate
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
12 participants
Where
1 siteSwitzerland
Study dates
Oct 2011to Jan 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Men only
  • No healthy volunteers
  • Adult

Who may be able to join

  • no cold or temperature at beginning or during the study
  • between 18 and 45 years of age
  • active in endurance sports (3 to 5 times per week a moderate to hart training)
  • non-smoker
  • no known cardiovascular or orthopedic problems
  • no known limitations of kidney function
Show all 9Show fewer
  • no bearer of a cardiac pacemaker
  • no medications with direct influence on the measurements. The whole intake of medicaments has to be declared in the health questionnaire by the participant.
  • requirements of the health questionnaire fulfilled

Who cannot join

  • male and age under 18 or over 45 years
  • cold or temperature at the beginning or during the study
  • untrained (less than 3 moderate trainings per week)
  • smoker
  • cardiovascular or orthopedic problems
  • limitations of the kidney function
Show all 9Show fewer
  • bearer of a cardiac pacemaker
  • medication with direct influence on the measurements. The whole intake of medicaments has to be declared in the health questionnaire by the participant.
  • requirements of the health questionnaire not fulfilled

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • University Hospital Zurich, Division of Neurology

    Zurich, Canton of Zurich, 8091

Other trials in Switzerland

About this study

During endurance exercise in the heavy and severe intensity domains, the rate at which metabolites that have been associated with the fatigue process (e.g. Pi, ADP, H, and extracellular K) accumulate increases. possibly leading to exercise cessation. Sodium bicarbonate, as a nutritional supplement, has gained attention over the past decades, because it might delay of offset fatigue. To date, there is a controversial discussion about which delivery mode (amount and frequency) might be best in optimizing endurance performance. Since the high ion load consequent to multiple ingestions might increase plasma volume, and consequently decrease bicarbonate concentrations, single acute ingestion could be more beneficial. However, in multi-day competitions or tournaments it might be necessary to use the supplement on a daily basis. Here, the investigators aim at investigating the effects of single dose or multiple dose (on five consecutive days) administration of bicarbonate vs. placebo increases endurance performance and acid-base homeostasis in trained male endurance athletes.

Conditions
Performance
Being tested
Sodium bicarbonate, Placebo

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Sodium bicarbonateDietary supplement

    Ergogenic effect

  • PlaceboDietary supplement

    Placebo effect

Study groups in NCT01621074
Study groupRoleWhat they receive
Sodium bicarbonateActive comparatorNot described
Receives: Dietary Supplement: Sodium bicarbonate
PlaceboPlacebo comparatorNot described
Receives: Dietary Supplement: Placebo

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time-to-exhaustion

    Measured: 5 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Jun 2012 (estimated)
  2. Study startOct 2011
  3. Primary completionAug 2012
  4. Study completionJan 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Allocation
Randomised
Intervention model
Crossover
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
12 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01621074
Sponsor's protocol ID
nbc
Status last verified
Apr 2013
First submitted
12 Jun 2012
Last updated
12 Apr 2013
Results posted
No
Data monitoring committee
No

Publications

  • Mueller SM, Gehrig SM, Frese S, Wagner CA, Boutellier U, Toigo M. Multiday acute sodium bicarbonate intake improves endurance capacity and reduces acidosis in men. J Int Soc Sports Nutr. 2013 Mar 26;10(1):16. doi: 10.1186/1550-2783-10-16.

    PubMed 23531361

Questions about this trial

What is this clinical trial studying?

A study testing Sodium bicarbonate in people with Performance, run by University of Zurich at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Apr 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time-to-exhaustion (time frame: 5 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01621074, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Apr 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in